Clinical and Aetiological Patterns of Paediatric Heart Failure in Nigeria: Insights Into Soluble ST2 as an Emerging Biomarker
This study conducted in Nigeria reveals that paediatric heart failure is primarily driven by pneumonia, severe malarial anaemia, and congenital heart disease, while demonstrating that significantly elevated plasma soluble ST2 levels in affected children vary by aetiology, suggesting its potential utility as a biomarker for myocardial stress in this population.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
In many parts of the world, a child's heart can fail not because of the wear and tear that affects adults, but because of infections, severe anemia, or heart defects present from birth. When the heart cannot pump enough blood to meet the body's needs, the child enters a state of heart failure, a condition that is difficult to spot in its early stages, especially in young children who cannot describe their symptoms. Doctors have long relied on physical signs like a rapid heartbeat, fast breathing, and an enlarged liver to make this diagnosis, but these signs can be vague or appear late in the disease process. To improve care, researchers are looking for biological signals in the blood that act as early warning lights. One such signal is a protein called soluble ST2, which the heart releases when it is under stress or beginning to change shape due to strain. While this protein is well-known as a marker of heart trouble in adults, its behavior in children, particularly in Africa where the causes of heart failure differ from those in wealthier nations, has remained a mystery.
A team of researchers at the University of Benin Teaching Hospital in Nigeria set out to fill this gap by studying children who had been admitted with heart failure. They gathered a group of 204 children with the condition and compared them to 204 healthy children of the same age and sex. The researchers carefully recorded details about the children's lives, their physical measurements, and their vital signs, while also drawing blood to measure the levels of the stress protein. They wanted to see not only if the protein levels were different in sick children compared to healthy ones, but also if the levels changed depending on what was causing the heart failure in the first place.
The study revealed that heart failure in this Nigerian setting is a condition that strikes very young children, with nearly half of the patients being under one year old. It is also a disease of poverty; more than two-thirds of the children with heart failure came from lower socioeconomic backgrounds. The causes were distinct from those seen in high-income countries. Instead of blocked arteries or high blood pressure, the leading triggers were severe malarial anemia, pneumonia, and congenital heart defects. Malaria, which destroys red blood cells and leads to severe anemia, was the single most common cause, followed closely by pneumonia. These preventable infections, combined with a lack of access to consistent healthcare, created a perfect storm for the heart to fail.
When the researchers looked at the children's physical state, the signs of struggle were clear. The sick children had significantly faster heart rates and breathing rates than the healthy controls, and their blood oxygen levels were lower. They were also thinner for their age, a sign that their bodies were struggling to get enough nutrition or were burning energy too fast to keep up with the demands of the failing heart. Most of the children presented with mild to moderate heart failure, suggesting that many were caught before the condition became critical, though a significant number still arrived with moderate disease, indicating that delays in seeking care remain a challenge.
The most significant finding of the study concerned the stress protein in the blood. The researchers found that children with heart failure had much higher levels of soluble ST2 than the healthy children. The median level in the sick group was 6.26 nanograms per milliliter, compared to 4.05 nanograms per milliliter in the healthy group. This difference was consistent across all age groups, suggesting that the protein is a reliable indicator that the heart is under stress, regardless of how old the child is. Furthermore, the level of the protein was not the same for every cause of heart failure. Children whose heart failure was linked to cancer or pericardial disease had the highest levels, while those with pneumonia or sickle cell anemia had lower levels. This variation suggests that the protein might tell doctors not just that the heart is struggling, but also hint at the specific type of strain it is enduring.
The study did not find that the protein levels were different between boys and girls, nor did it show a strong link between the child's age and the amount of protein in their blood among the sick children. This stability across different demographics is a promising sign, as it means the test could be applied broadly without needing complex adjustments for age or gender. However, the researchers were careful to note that this was a snapshot in time. Because the study looked at children only once, it could not prove that high levels of the protein predict who will get worse or who will recover. It simply showed that the protein is present and elevated when the heart is in trouble.
The implications of these findings are twofold. First, they highlight that in Nigeria, the fight against pediatric heart failure is largely a fight against malaria, pneumonia, and anemia. Preventing these infections and treating them quickly is the most effective way to stop heart failure from starting. Second, the study suggests that measuring soluble ST2 could become a useful tool for doctors. If a child comes in with vague symptoms, a high level of this protein could help confirm that the heart is indeed under stress, allowing for earlier and more targeted treatment. While the researchers call for more long-term studies to confirm how well this marker predicts outcomes, the evidence from this work points to a future where a simple blood test could help save the hearts of children in resource-limited settings.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.